A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial)
Date
2013
Authors
Maki, K.
Orloff, D.
Nicholls, S.
Dunbar, R.
Roth, E.
Curcio, D.
Johnson, J.
Kling, D.
Davidson, M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Clinical Therapeutics: the international peer-reviewed journal of drug therapy, 2013; 35(9):1400-1411
Statement of Responsibility
Kevin C. Maki, David G. Orloff, Stephen J. Nicholls, Richard L. Dunbar, Eli M. Roth, Danielle Curcio, Judith Johnson, Douglas Kling, and Michael H. Davidson
Conference Name
Abstract
Abstract not available
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2013 Elsevier HS Journals, Inc. All rights reserved.